We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+32.72%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$4.56B
AUM Growth
+$501M
Cap. Flow
-$460M
Cap. Flow %
-10.1%
Top 10 Hldgs %
89.62%
Holding
82
New
4
Increased
7
Reduced
13
Closed
34

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$282M
2
NTES icon
NetEase
NTES
+$105M
3
ZTO icon
ZTO Express
ZTO
+$61.5M
4
JD icon
JD.com
JD
+$42.3M
5
BIDU icon
Baidu
BIDU
+$26.5M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$507M
2
BEKE icon
KE Holdings
BEKE
+$182M
3
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$38M
4
DASH icon
DoorDash
DASH
+$27M
5
DHR icon
Danaher
DHR
+$26.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 45.15%
2 Healthcare 37.98%
3 Communication Services 6.33%
4 Real Estate 4.75%
5 Financials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONC
1
BeOne Medicines Ltd
ONC
$33.9B
$1.16B 25.52%
5,176,906
BABA icon
2
Alibaba
BABA
$275B
$937M 20.57%
8,827,600
+3,448,152
+64% +$282M
PDD icon
3
Pinduoduo
PDD
$126B
$643M 14.11%
4,766,780
-4,125,667
-46% -$507M
LEGN icon
4
Legend Biotech
LEGN
$3.64B
$323M 7.1%
6,636,496
VIPS icon
5
Vipshop
VIPS
$7.22B
$247M 5.43%
15,720,322
+914,322
+6% +$12.2M
NTES icon
6
NetEase
NTES
$82.8B
$242M 5.31%
2,588,943
+1,203,129
+87% +$105M
BEKE icon
7
KE Holdings
BEKE
$17.6B
$216M 4.75%
10,868,688
-12,303,642
-53% -$182M
TCOM icon
8
Trip.com Group
TCOM
$29.2B
$105M 2.32%
1,774,432
+389,790
+28% +$18M
AVBP icon
9
ArriVent BioPharma
AVBP
$1.36B
$105M 2.31%
4,484,672
FUTU icon
10
Futu Holdings
FUTU
$14.3B
$101M 2.21%
1,051,089
+335,000
+47% +$21.3M
ZTO icon
11
ZTO Express
ZTO
$18.3B
$74.4M 1.63%
3,003,008
+2,966,708
+8,173% +$61.5M
JD icon
12
JD.com
JD
$43.2B
$64M 1.41%
1,600,000
+1,539,000
+2,523% +$42.3M
ENFN
13
DELISTED
Enfusion, Inc.
ENFN
$47.2M 1.04%
4,975,183
KNSA icon
14
Kiniksa Pharmaceuticals
KNSA
$6.12B
$39.6M 0.87%
1,582,635
-1,561,921
-50% -$38M
CTKB icon
15
Cytek Biosciences
CTKB
$563M
$36.9M 0.81%
6,657,030
BIDU icon
16
Baidu
BIDU
$35.5B
$31.6M 0.69%
+300,000
New +$26.5M
YUMC icon
17
Yum China
YUMC
$15.9B
$30M 0.66%
+665,863
New +$22.2M
BBIO icon
18
BridgeBio Pharma
BBIO
$16.5B
$26.1M 0.57%
1,023,950
-366,703
-26% -$9.63M
YSG
19
Yatsen Holding
YSG
$312M
$23.8M 0.52%
6,987,839
HTHT icon
20
Huazhu Hotels Group
HTHT
$13.3B
$21.2M 0.46%
568,613
CTNM
21
Contineum Therapeutics
CTNM
$532M
$12.8M 0.28%
669,337
SOHU
22
Sohu.com
SOHU
$348M
$11.2M 0.25%
713,400
NBP
23
NovaBridge Biosciences American Depositary Shares
NBP
$191M
$8.57M 0.19%
6,909,220
GOSS icon
24
Gossamer Bio
GOSS
$92.8M
$4.91M 0.11%
4,974,041
TSM icon
25
TSMC
TSM
$1.95T
$3.37M 0.07%
19,395
-47,405
-71% -$8.08M

Similar funds

HHLR Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, HHLR Advisors held 82 positions worth $4.56B, up 12% from $4.05B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

HHLR Advisors withdrew a net $460M in Q3 2024, closing 34 positions and reducing 13 holdings. Its most notable exit was DoorDash, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 45% of assets, down from 48% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, HHLR Advisors opened a new position in Baidu worth $31.6M.

  • HHLR Advisors's largest Q3 2024 buy was Baidu: 300,000 shares worth $31.6M.
  • HHLR Advisors added most to Alibaba in Q3 2024, an estimated $282M increase.
  • HHLR Advisors's biggest Q3 2024 reduction was Pinduoduo, cutting an estimated $507M.
  • HHLR Advisors fully exited DoorDash in Q3 2024, selling an estimated $27M.
  • HHLR Advisors's ten largest holdings make up 90% of its $4.56B portfolio in Q3 2024.
  • HHLR Advisors opened 4 new positions and closed 34 in Q3 2024.
  • HHLR Advisors's portfolio value rose 12% quarter-over-quarter to $4.56B.

Based on HHLR Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.